Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Depression Severe: early-phase trial registry

2 of 4 indexed Depression Severe trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Depression Severe: 4 US clinical trials tracked, 2 recruiting.

Depression Severe is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Kintsugi Mindful Wellness, running 2 of these trials.

Enrollment posture brief

Registry condition depression-severe

OPEN 2 | RECR 50% | LATE 0 | EARLY 1 | RANK #4115 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Depression Severe (this)50%
Open-enrollment share among volume-matched conditions near Depression Severe

Depression Severe lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Depression Severe on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Depression Severe is recruiting above its size-band peers.

    2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Depression Severe records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Kintsugi Voice Device Device
2 trials
TNX-601 ER Drug
1 trials
Behavioral Activation Other
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Depression Severe trials. A trial with sites in several states counts in each.

California 3 trials
Texas 1 trials
Idaho 1 trials
Georgia 1 trials
Florida 1 trials
Connecticut 1 trials
Colorado 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Depression Severe page

4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Depression Severe condition card totals 4 registered trials; most-linked intervention Kintsugi Voice Device; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.